Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126

Affiliations

• ¹ 1Department of Endocrinology & Diabetes, Western Health, Melbourne, Australia.
• ² 2Department of Medicine, Western Health, The University of Melbourne, Australia.
• ³ 3Department of Endocrinology and Diabetes, Eastern Health, Melbourne, Australia.
• ⁴ 4Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
• ⁵ 5Department of Endocrinology, Austin Health, Melbourne, Australia.
• ⁶ 6Melbourne Medical School, The University of Melbourne, Australia.
• ⁷ 7Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Australia.
• ⁸ 8School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.
• ⁹ 9Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia.
• ¹⁰ 10Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Australia.
• ¹¹ 11Department of Anaesthesia, Austin Health, Melbourne, Australia.
• ¹² 12Department of Gastroenterology, Alfred Health, Melbourne, Australia.
• ¹³ 13Department of Endoscopic Services, Western Health, Melbourne, Australia.
• ¹⁴ 14Department of Anaesthesia, Pain and Perioperative Medicine, Eastern Health, Melbourne, Australia.
• ¹⁵ 15Department of Gastroenterology, Austin Health, Melbourne, Australia.
• ¹⁶ 16Gastroenterological Nurses College of Australia, Melbourne, Australia.
• ¹⁷ 17Department of Medicine, Central Clinical School Monash University, Victoria, Australia.